Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Headache in aSAH
NCT02330094Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2014
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of gabapentin in aneurysmal subarachnoid hemorrhage (SAH) (2 arms), sponsored by Mayo Clinic. Primary endpoints: Average Numeric Pain Score at Day 7 and Average Narcotic Consumption at Day 7. Started Dec 2014; status: completed.
02
Drugs
gabapentin
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT02330094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02330094.